A study on measurement of KP-607 concentrations in nails (Phase I) Investigation on KP-607 concentrations in nails when applied repeatedly to toenails in patients with onychomycosis.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2018
At a glance
- Drugs KP-607 (Primary)
- Indications Onychomycosis
- Focus Pharmacokinetics
- Sponsors Kaken Pharmaceutical
- 01 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 25 Sep 2018 Status changed from not yet recruiting to recruiting.
- 12 Sep 2018 New trial record